| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/15/1996 | WO1996004395A1 Recombinant virus vectors |
| 02/15/1996 | WO1996004394A1 Hsv viral vector |
| 02/15/1996 | WO1996004393A2 Control of plant gene expression |
| 02/15/1996 | WO1996004392A2 Transgenic cereal plants |
| 02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
| 02/15/1996 | WO1996004390A1 Dna sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004387A1 Dna sequences coding for the human proteins tx and ty related to the interleukin-1beta converting enzyme |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004382A2 Secreted viral proteins useful for vaccines and diagnostics |
| 02/15/1996 | WO1996004381A1 S. aureus fibronectin binding protein polypeptides and uses thereof |
| 02/15/1996 | WO1996004380A1 D2d3 polypeptide from staphylococcus aureus and uses thereof |
| 02/15/1996 | WO1996004379A1 Methods and compositions for the expression of a bone and prostate derived growth factor |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004377A1 Production of tissue factor pathway inhibitor |
| 02/15/1996 | WO1996004376A1 Hepatitis a virus receptor and methods of use |
| 02/15/1996 | WO1996004375A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 02/15/1996 | WO1996004374A1 Oligonucleotide recognising a non linear nucleic acid sequence, therapeutic applications thereof and method for preparing same |
| 02/15/1996 | WO1996004373A2 Recombinant production of biologically active peptides and proteins |
| 02/15/1996 | WO1996004372A1 Ikaros transgenic cells and animals |
| 02/15/1996 | WO1996004369A1 Polypeptide having cold-resistant pyruvate phosphate dikinase activity, dna coding for the polypeptide, recombinant vector containing the dna, and transformed plant |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004313A1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | WO1996004307A1 Aspb1 insulin analogs |
| 02/15/1996 | WO1996004304A1 Fibrin-binding peptides, dna coding therefor and uses thereof |
| 02/15/1996 | WO1996004295A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | WO1996004294A1 Nucleic acid to initiate the activity of ribonuclease h or reverse transcriptase |
| 02/15/1996 | WO1996004019A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | WO1996004010A1 Vr-2332 viral nucleotide sequence and methods of use |
| 02/15/1996 | WO1996003997A2 Treatment of cancer using hsv mutant |
| 02/15/1996 | WO1996003977A1 A liposomal delivery system for biologically active agents |
| 02/15/1996 | WO1996003883A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 02/15/1996 | WO1996002645A3 Htk ligand |
| 02/15/1996 | WO1995035383A3 Plant genes affecting gibberellic acid biosynthesis |
| 02/15/1996 | WO1995034650A3 Mn gene and protein |
| 02/15/1996 | WO1995032285A3 Transgenic arthritic mice |
| 02/15/1996 | WO1995026982A3 Malaria peptides |
| 02/15/1996 | WO1995021250A3 Production of pharmaceutical-grade plasmid dna |
| 02/15/1996 | DE4428402A1 Gentherapeutisches Verfahren unter Verwendung von DNA-Vektoren ohne Selektionsmarker-Gen Gene therapy methods using DNA vectors without selectable marker gene |
| 02/15/1996 | CA2328638A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | CA2196776A1 Diagnosis and treatment of cell proliferative disease having clonal macrophage involvement |
| 02/15/1996 | CA2196679A1 Target specific screens and their use for discovering small organic molecular pharmacophores |
| 02/15/1996 | CA2196604A1 Method and apparatus for performing amplification of nucleic acid on supports |
| 02/15/1996 | CA2196569A1 Aspb1 insulin analogs |
| 02/15/1996 | CA2196290A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | CA2196285A1 Contraceptive vaccine |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2196190A1 Ikaros transgenic cells and animals |
| 02/15/1996 | CA2196168A1 Recombinant virus vectors |
| 02/15/1996 | CA2195965A1 Hsv viral vector |
| 02/15/1996 | CA2195864A1 5'-dithio-modified oligonucleotides |
| 02/15/1996 | CA2195672A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | CA2195312A1 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| 02/15/1996 | CA2195206A1 Transgenic cereal plants |
| 02/15/1996 | CA2194488A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | CA2192980A1 Detection of mycobacteria |
| 02/15/1996 | CA2172273A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/14/1996 | EP0696640A2 Recombinant antigen from the NS3 region of hepatitis C virus |
| 02/14/1996 | EP0696638A1 Process for lysing mycobacteria |
| 02/14/1996 | EP0696597A2 Monoclonal antibodies for selective immunological determination of high molecular weight intact laminin forms in body fluids |
| 02/14/1996 | EP0696325A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
| 02/14/1996 | EP0696324A1 Integrative dna segment comprising gene encoding insecticidal protein |
| 02/14/1996 | EP0696323A1 Recombinant alanine racemase and gapdh from tolypocladium |
| 02/14/1996 | EP0696322A1 METHODS AND COMPOSITIONS FOR $i(SALMONELLA)-BASED VACCINES |
| 02/14/1996 | EP0696321A1 Macrophage inflammatory protein variants |
| 02/14/1996 | EP0696320A1 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 02/14/1996 | EP0696319A1 An enzyme exhibiting pectin methylesterase activity |
| 02/14/1996 | EP0696317A1 HUMAN $i(SYK) |
| 02/14/1996 | EP0696206A1 Adenoviruses having modified fiber proteins |
| 02/14/1996 | EP0696205A1 Use of neuro-derived fetal cell lines for transplantation therapy |
| 02/14/1996 | EP0696204A1 Recombinant fowlpox viruses and uses thereof |
| 02/14/1996 | EP0696200A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
| 02/14/1996 | EP0664836B1 Methods for sequencing synthetic oligonucleotides containing non-phosphodiester internucleotide linkages |
| 02/14/1996 | EP0389538B1 yETHOD OF PURIFYING RECOMBINANT t-PA FROM CORRESPONDING HOST CELL PROTEINS |
| 02/14/1996 | EP0205579B1 Methods and compositions useful in the diagnosis and treatment of autoimmune diseases |
| 02/14/1996 | CN1116859A Detection of synthetic oligonucleotides extracted from body fluids or tissues |
| 02/14/1996 | CN1116655A Process for gene tranfer into plant cells |
| 02/14/1996 | CN1030999C Process for preparation of trypsin inhibitor |
| 02/13/1996 | US5491288 Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants |
| 02/13/1996 | US5491285 Phytophthora resistance gene of catharanthus and its use |
| 02/13/1996 | US5491284 Nude mouse model for neoplastic disease |
| 02/13/1996 | US5491283 Transgene expressed in bone marrow cells; effective in promoting leukemia |
| 02/13/1996 | US5491133 Contacting eukaryotic cell in vitro with oligodeoxynucleotide which has complementarity for and is hybridizable to specifed messenger rna region and has modified phosphodiester linkage resistant to exonuclease degradation |
| 02/13/1996 | US5491088 Genetic engineering |
| 02/13/1996 | US5491086 Heat resistant enzyme proteins as vectors for genetic engineering |
| 02/13/1996 | US5491084 Possesses regulatory element from a gene; culturing cells permitting expression of protein |
| 02/13/1996 | US5491081 Genetic engineering; introgressing soybean cyst nematode resistance into elite soybean germplasm using nucleic acid marker |
| 02/13/1996 | US5491080 Genetic engineering of integrating a dna sequence encoding a protein specifically breaking a double-strain rna into a plant chromosome |
| 02/13/1996 | US5491079 Promoterless foreign gene integrated in Streptococcus thermophilus |
| 02/13/1996 | US5491076 Heterologous protein in plants |
| 02/13/1996 | US5491075 Culture product |
| 02/13/1996 | US5491074 Joining peptides by attaching association hexapeptide to each, mixing fusion complexes formed to dimerize association peptide |
| 02/13/1996 | US5491073 Cloning of chicken anaemia DNA |
| 02/13/1996 | US5491066 Specifically reacts with active human ceruloplasmin; diagnosis of wilson's disease |
| 02/13/1996 | US5491065 Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF |